[HTML] springer.com

[HTML][HTML] Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki67

CG Genc, M Falconi, S Partelli, F Muffatti… - Annals of surgical …, 2018 - Springer
Background Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and …
被引用次数：111 相关文章

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

CG Genç, M Falconi, S Partelli… - Annals of …, 2018 - researchinformation.amsterdamumc …
Background: Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and …

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

CG Genç, M Falconi, S Partelli… - Annals of surgical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and …

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

C Genç, M Falconi, S Partelli, F Muffatti… - Annals of Surgical …, 2018 - repub.eur.nl
Background: Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and …
[PDF] core.ac.uk

[PDF][PDF] Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

CG Genç - Ann Surg Oncol, 2018 - core.ac.uk
Background. Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (pan-NETs) and …

[引用][C] Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

CG Genç, M Falconi, S Partelli, F Muffatti… - Annals of Surgical …, 2018 - cir.nii.ac.jp
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.

CG Genç, M Falconi, S Partelli, F Muffatti… - Annals of Surgical …, 2018 - europepmc.org
BACKGROUND: Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and …

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

CG Genc, M Falconi, S Partelli, F Muffatti… - ANNALS OF …, 2018 - iris.unisr.it
Background: Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and …
[HTML] nih.gov

[HTML][HTML] Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

CG Genç, M Falconi, S Partelli, F Muffatti… - Annals of Surgical …, 2018 - ncbi.nlm.nih.gov
Background Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and …
[PDF] eur.nl

[PDF][PDF] Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

CG Genç - Ann Surg Oncol, 2018 - pure.eur.nl
Background. Despite evidence of different malignant potentials, postoperative follow-up
assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (pan-NETs) and …